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Abstract
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, in association with
clinical treatment failures, has become a major therapeutic problem. This issue is especially relevant to methicillin-resistant
S. aureus (MRSA) strains in the context of invasive endovascular infections. In the current study, we used three well-
characterized and clinically-derived DAP-susceptible (DAP-S) vs. resistant (DAP-R) MRSA strain-pairs to elucidate potential
genotypic mechanisms of the DAP-R phenotype. In comparison to the DAP-S parental strains, DAP-R isolates demonstrated
(i) altered expression of two key determinants of net positive surface charge, either during exponential or stationary growth
phases (i.e., dysregulation of dltA and mprF), (ii) a significant increase in the D-alanylated wall teichoic acid (WTA) content in
DAP-R strains, reflecting DltA gain-in-function; (iii) heightened elaboration of lysinylated-phosphatidylglyderol (L-PG) in
DAP-R strains, reflecting MprF gain-in-function; (iv) increased cell membrane (CM) fluidity, and (v) significantly reduced
susceptibility to prototypic cationic host defense peptides of platelet and leukocyte origins. In the tested DAP-R strains,
genes conferring positive surface charge were dysregulated, and their functionality altered. However, there were no
correlations between relative surface positive charge or cell wall thickness and the observed DAP-R phenotype. Thus, charge
repulsion mechanisms via altered surface charge may not be sufficient to explain the DAP-R outcome. Instead, changes in
the compositional or biophysical order of the DAP CM target of such DAP-R strains (i.e., increased fluidity) may be essential
to this phenotype. Taken together, DAP-R in S. aureus appears to involve multi-factorial and strain-specific adaptive
mechanisms.
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Introduction
Daptomycin (DAP) is a calcium-dependent lipopeptide antibi-
otic with potent bactericidal effects against most Gram-positive
pathogens [1,2]. Since its release for use in 2003 for skin and soft
tissue infections, followed by approval for Staphylococcus aureus
bacteremia and right-sided endocarditis in 2006, DAP has become
a key antibiotic for invasive staphylococcal infections. This is
especially relevant to methicillin-resistant S. aureus (MRSA)
infections in the era of rising vancomycin MICs associated with
clinical treatment failures [3–5], as well as vancomycin (VAN)-
intermediate S. aureus (VISA)-related infections [2,5,6]. Recently,
there have been an alarming number of reports of both S. aureus
and enterococcal DAP-resistant (DAP-R) strains emerging during
DAP treatment failures [7–12]. The mechanisms by which such
organisms develop resistance to the microbicidal effects of DAP
are likely multi-modal and organism-dependent [9,13–18]. Thus,
integrative genotypic and phenotypic profiles among DAP-R S.
aureus strains differ substantially from those defined among DAP-
R enterococci [9,10,13,14,16–18]. Moreover, although a principle
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mechanism of DAP action appears to be perturbation of the
bacterial cell membrane (CM), key impacts upon cell wall (CW)
turnover processes seem to play a cardinal role in this regard [19–
21]. Since DAP unambiguously requires calcium complexing to
execute its CM-targeting and subsequent bactericidal effects, this
agent acts similarly to cationic antimicrobial peptides involved in
innate host defenses (e.g., from PMNs and platelets [22,23]). The
range of potential phenotypic adaptations that may be associated
with staphylococcal DAP-R include: i) increased positive surface
charge (‘charge-repulsion hypothesis’) [9,17,18,24]; ii) altered CM
fatty acid composition resulting in altered CM fluidity [14,25,26]
(‘membrane order hypothesis’); iii) increased CM carotenoid
pigment content yielding very rigid CMs [27]; iv) a combination
of factors; for example, enhanced CM content of positively-
charged phospholipids, as well as increased D-alanylation of CW
teichoic acid, resulting in reduced affinity of DAP to the CM target
[28]; and v) augmented synthesis of CW teichoic acid, creating a
thickened CW phenotype and a putative mechanical barrier to
DAP penetration to reach its CM target [28,29].
The above phenotypic correlates of DAP-R in S. aureus point
to specific genes as potentially involved in this resistance process.
In this regard, the mprF operon (involved in lysinylation of CM
phosphatidylglycerol [PG] to synthesize lysyl-PG [L-PG], as well
as to translocate this latter positively-charged species to the outer
CM) and the dlt operon (responsible for the D-alanylation of CW
teichoic acid) have received particular attention [17,24,28–33].
However, studies have varied widely in ascribing causality to these
two loci in DAP-R S. aureus strains, since a broad range of
genotypic correlates with the DAP-R phenotype have emerged,
including: i) acquisition of gain-in-function single nucleotide
polymorphisms (SNPs) in the mprF ORF [9,11,24,25,34]; ii)
over-expression of dlt genes [17]; and iii) dysregulation of both
mprF and dlt expression profiles [17,24,29]. Recently, Cafiso et al
[31] studied three clinical MRSA strain-sets in which DAP-R
evolved during treatment, and were able to pinpoint dltA
overexpression (especially in strains acquiring a concomitant
SNP in mprF) as potentially causal in the DAP-R phenotype.
This intriguing investigation was, however, somewhat limited, in
that within the DAP-S and DAP-R strain-sets: i) there was no
growth phase-dependent gene expression profiling performed; ii)
there were no phenotypic correlates of dlt and mprF over-
expression studied, especially surface charge measurements; iii)
specific phenotypic readouts of dlt and mprF over-expression were
not quantified (i.e., CW D-alanylation and CM L-PG synthesis
and/or translocation, respectively [25,28,32]); iv) other parame-
ters of CM physiology previously associated with DAP-R (e.g., CM
fluidity and fatty acid contents) were not queried [9,27,35]; and v)
assessment of DAP-R isolates for in vitro ‘cross-resistance’ with
several prototypical host defense cationic peptides (HDPs)
involved in staphylococcal pathogenesis was not performed
[9,18,25,35]. The latter cross-resistance phenomenon has been
well-chronicled for other DAP-R S. aureus strains [25]. The
current study, employing the same previously published DAP-S/
DAP-R strain-pairs [31], was designed to address these limitations,
and to further characterize potential mechanisms of DAP-R in
these strains.
Methods and Materials
Bacterial strains
The three clinically-derived DAP-S/DAP-R MRSA strain-pairs
used in the current study (Table 1) have been described in detail
before [31]. Briefly, the epidemiologically unrelated stran-pairs
were isolated from different patients, were from different clinical
infection types (skin and soft tissue; bacteremia), and were from
three different Italian hospitals. All three patients had received and
failed therapy with the glycopeptides antibiotic, teicoplanin, and
were subsequently treated with DAP [31]. Each strain-pair
included an initial pre-DAP therapy DAP-S MRSA strain and
an isogenic DAP-R isolate obtained during DAP therapy.
Isogenicity of each strain-pair was confirmed by identical
outcomes of several discriminative genotypic assays within each
DAP-S and DAP-R strain-pair, including: pulse field gel electro-
phoresis typing (PFGE), agr typing, multi-locus sequence typing
and staphylococcal casette chromosome (SCCmec) typing. The
three strain-pairs were previously characterized for mutations in
the mprF genes. Two of the three DAP-R variants within each
strain-pair exhibited a non-synonomous SNP in the mprF ORF
(Table 1), while the third strain-set did not. Of note, these two
SNPs occurred in previously described ‘‘hotspots’’ within the mprF
locus associated with MprF gains-in-function and the DAP-R
phenotype [9,32,34]. The above genotypic data for these three
strain-pairs have been previously published [31].
MIC testing
Oxacillin, vancomycin and DAP MICs were performed
according to CLSI guidelines [36]. These data have been
previously reported (Table 1) [31].
Surface charge
The cytochrome c binding assay was performed as a surrogate
measure of the relative net positive surface charge of the strain-
pairs as described previously [17,18,37]. Briefly, cells were grown
overnight in TSB media, washed with 20 mM MOPS buffer
(pH 7.0) three times and resuspended in the same buffer at
OD578 = 1.0. Cells were incubated with 0.5 mg/ml cytochrome c
for 10 minutes and the amount of cytochrome c remaining in the
supernatant was determined spectrophotometrically at OD530 nm.
The more unbound cytochrome c that was detected in the
supernatant, the more net positively charged the bacterial surface.
Data were converted and expressed as mean (6 SD) amount of
bound cytochrome c. At least three independent runs were
performed on separate days.
Wall teichoic acid (WTA) isolation and purification
S. aureus CW and WTA were specifically isolated as described
in detail before [39,40]. In brief, bacteria were grown overnight in
B-Medium (1% peptone, 0.5% yeast extract, 0.1% glucose, 0.5%
NaCl and 0.1% K2HPO4) containing 0.25% (wt/vol) glucose,
washed twice in sodium acetate buffer (20 mM, pH 4.7) and
disrupted in the same buffer with glass beads for 1 h on ice in a cell
disruptor (Euler). Protein-free CW was isolated, and WTA was
released by treatment with 5% trichloroacetic acid in sodium
acetate buffer for 4 h at 60uC. The CWs were removed by
centrifugation and WTA was quantified by determining its
inorganic phosphate (Pi) content as described before [40]. The
isolation was performed in triplicate for each strain, and assayed in
triplicate for their respective Pi content.
Quantification of D-alanylated WTA content
The D-alanylation of the WTA polymers was assayed and
quantified as described before [41]. In brief, D-alanine esters were
hydrolyzed by a mild alkaline hydrolysis carried out at 37uC for
1 h in 0.1 M NaOH. The supernatant was neutralized, dried
under vacuum, and used for pre-column derivatization with
Marfey’s reagent (1-fluoro-2, 4-dinitrophenyl-5-L-alanine amide;
Sigma). Amino acid derivates (detection at 340 nm) were then
Relative Roles of mprF and dlt in DAP-R MRSA
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separated as described before and analyzed with the ChemStation
software. Data were expressed as percent of WTA (6 SD) that was
D-alanylated. A minimum of three independent runs was
performed.
Cell wall (CW) thickness
The CW thickness of study strains were measured by
transmission electron microscopy (TEM; [25,26]). The mean
CW thickness (nm 6 SD) of 100 cells was determined for the
strains at a constant magnification of 190,0006 (JEOL, Model#
100CX, Tokyo, Japan) using digital image capture and morpho-
metric measurement (Advanced Microscopy Techniques v54,
Danvers, MA).
Host defense peptides (HDPs)
Thrombin-induced platelet microbicidal proteins (tPMPs) were
obtained from thrombin-stimulated rabbit platelets as previously
described [43]. This preparation contains several tPMPs, but
predominantly tPMP-1. The bioequivalency (activity in mg/ml) of
the tPMP preparation was determined as detailed before, using a
Bacillus subtilis bioassay [9]. Purified human neutrophil defensin-
1 (hNP-1) and LL-37 (prevalent in neutrophils and skin epithelium
[22,44,45]) were purchased from Peptides International (Louis-
ville, KY). RP-1 (a synthetic congener of the microbicidal domain
of the platelet factor-4 family of kinocidins) was synthesized as
previously detailed [46].
Susceptibilities to HDPs
For tPMPs and RP-1, a microtiter bactericidal assay was carried
out in minimal liquid nutrient medium (Eagles minimal essential
media [MEM]) in appropriate buffers [25]; the hNP-1 and LL-37
killing assays were performed in 1% BHI +10 mM potassium
phosphate buffer (PPB). A final bacterial inoculum of 103
stationary phase CFU was employed. The peptide concentrations
used in the 2 h killing assays were: 1.5 or 2.0 mg/ml bioactivity
equivalent for tPMPs; 5 or 10 for hNP-1; and 0.5 and 1 mg/ml for
RP-1 and LL-37. After extensive pilot studies, these peptide
concentrations were selected based on: (i) sub-lethality, with ,
50% reductions in counts of the parental DAP-susceptible (DAP-S)
strain; and (ii) encompassing peptide concentrations used in prior
investigations of HDP:S. aureus interactions [25]. After 2 h
peptide exposure, samples were obtained and processed for
quantitative culture to evaluate the extent of killing by each
HDP condition. Final data were expressed as mean (6 SD)
percent survival rate. Since there is no bona fide ‘‘resistance’’
breakpoint for HDPs, the mean percent survival (6 SD) was
statistically evaluated for potential correlates of HDP and DAP
susceptibility profiles. Data included a minimum of three
experiments performed on separate days.
CM phospholipid (PL) and amino-PL translocation
(asymmetry)
To investigate potential correlates between mprF polymor-
phisms and CM features, PLs were extracted from study strains
under specific test conditions as described [26]. The major CM
PLs of S. aureus (PG; L-PG and cardiolipin [CL]) were separated
by two-dimensional thin-layer chromatography (2-D TLC) using
Silica 60 F254 HPTLC plates (Merck). Fluorescamine labeling (a
fluorophore which binds only to positively charged PLs, such as L-
PG, and which does not penetrate the outer CM leaflet), combined
with ninhydrin staining localization, was used within the 2-D TLC
plate assay to assess the translocation of L-PG between the inner-
to-outer CM bilayer [13,17,26]. First-dimension chloroform-
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methanol–25% ammonium hydroxide (65:25:6, by volume) in the
vertical orientation and second-dimension chloroform:water:-
methanol:glacial acetic acid:acetone (45:4:8:9:16, by volume) in
the horizontal orientation were used for the separation of the PLs
for further quantitation by phosphate estimation. PL identity was
confirmed using known PL standards. For quantitative analysis,
resulting isolated PLs (identified by iodine staining) were digested
at 180uC for 3 h with 0.3 ml 70% perchloric acid and the oxidized
derivatives quantified spectrophotometrically at OD660.
CM fatty acid composition
Given the impact of fatty acid composition on CM adaptability
to stress, the comparative fatty acid profiles of the DAP-S/DAP-R
strain-pairs were determined. Approximately 20 mg of bacterial
cells were harvested from late log phase growth preparations, and
then saponified, methylated, and fatty acid esters extracted into
hexane as described previously [17,26]. The resulting methyl ester
mixtures were separated by an Agilent 5890 dual-tower gas
chromatograph. Fatty acids were identified and quantified by a
microbial identification system (Sherlock 4.5; courtesy of Micro-
bial ID Inc., Newark, DE) [17,26].
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Figure 1. Relative positive surface charge by cytochrome c
binding. The graph shows percent of cytochrome c bound after
10 min of incubation with S. aureus cells at room temperature. Data
represent the means and standard deviations from three independent
experiments. *P,0.01 vs DAP-S parental strains.
doi:10.1371/journal.pone.0107426.g001
Figure 2. Cell wall teichoic acid (WTA) contents of the strain
sets. Dry mass of cell wall was quantified as [g dry weight/g wet
weight]. The amount of WTA was determined by a colorimetric assay
and expressed as [nmol Pi/mg cell wall; n = 5]. Statistical analysis was
performed by Student’s t-test. *P,0.05 vs DAP-S parental strain.
doi:10.1371/journal.pone.0107426.g002
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CM fluidity
CM fluidity was determined by fluorescence polarization
spectrofluorometry as detailed previously [9,25,26] using the
fluorescent probe 1,6-diphenyl-1,3,5-hexatriene (DPH). An inverse
relationship exists between polarization indices and the degree of
CM order (i.e., lower polarization indices [PI value] denotes a
greater CM fluidity) [9,25,26]. To address day-to-day biological
variability inherent to CM dynamics, these assays were performed
a minimum of six times for each strain on separate days.
DNA isolation and targeted mprF, dltA, and dltB
sequencing
Genomic DNA was isolated from S. aureus using the method of
Dyer and Iandolo [47]. PCR amplification of the mprF ORF was
performed as we have previously described, using the primers,
mprF-F-bam (59-CCCGGATCCAATTAGAATTGATGTGA-
AAAAATG-39) and mprF-R-sph (59-CCCGCATGCAGCGCTT-
CAGGCATAACTGT-39) [24].
PCR amplification of the dltA and dltB ORFs were performed as
we have described previously with primer pairs dltA-ORF-F (59-
CAGTGGCGACACACACAATA-39) and dltA-ORF-R (59-
GACTGGTAATAATGCAATTAAAGCAA-39), dltB-ORF-F (59-
TGGAACAATTGCCATTGACTT-39) and dltB-ORF-R (59-
TCCAACTGTTTGGAAAGA ATCA-39), respectively [17]. DNA
sequencing of the mprF and dlt genes was kindly performed at City of
Hope, Duarte, CA.
RNA isolation and qRT-PCR analysis for mprF and dltA
transcription
For RNA isolation, fresh overnight cultures of S. aureus strains
were used to inoculate NZY broth to an optical density at 600 nm
(OD600) of 0.1. Cells were harvested during both exponential
growth (2.5 h; OD = 0.5) and stationary phase (12 h). Total RNA
was isolated from the cell pellets by using the RNeasy kit (Qiagen,
Valencia, CA) and the FASTPREP FP120 instrument (BIO 101,
Vista, CA), according to the manufacturer’s recommended
protocols.
Quantitative real time PCR assay was carried out as detailed
previously [29,48]. Briefly, 1 mg of DNase-treated RNA was
reverse transcribed using the SuperScript III first-strand synthesis
kit (Invitrogen) according to the manufacturer’s protocols.
Quantification of cDNA levels was performed following the
instructions of the Power SYBR green master mix kit (Applied
Biosystems) on an ABI PRISM 7000 sequence detection system
(Applied Biosystems) or on a LightCycler using the Quanti Fast
SYBR green real-time (RT)-PCR kit (Qiagen). The mprF, dltA,
and gyrB genes were detected using specific primers and
computational methods as described before [29,48].
Results
HDP susceptibility profiles
As anticipated, the peptides exerted distinct efficacies against the
study strains (Table 2). RP-1 exhibited the greatest anti-staphy-
lococcal activity, including against stain 2C which exhibited high
level resistance to other peptides (Table 2). There was a general
trend for all HDPs tested, showing that the DAP-R isolate in each
strain-pair was significantly more resistant to peptide-mediated
killing than its DAP-S parental strain. This difference in HDP
killing profiles between DAP-S/DAP-R strain-pairs was most
dramatic for tPMPs and RP-1 of platelet origin, and LL-37 from
leukocytes, while being the least notable for hNP-1 (by far the least
active of the peptides against these study strains).
Surface charge (Figure 1)
Outcomes of relative positive surface charge comparisons
between DAP-S and DAP-R isolates varied substantially between
Figure 3. WTA D-alanylation in the DAP-S/DAP-R strain pairs.
The rate of D-alanylation of WTA repeating units was determined by
HPLC (n = 3). Statistical analysis was performed by Student’s t-test. *P,
0.05; **P,0.01 vs DAP-S parental strains.
doi:10.1371/journal.pone.0107426.g003
Table 3. Comparative fatty acid (FA) compositions of S. aureus study strains.
Strains FA species (% of fatty acid composition ± SD)
Iso-BCFA Anteiso-BCFA UFAs SFAs
1A 14.860.9 58.660.2 8.660.9 15.260.2
1C 15.960.9 57.760.2 9.360.9 14.560.1
2A 17.560.7 55.762.1 9.061.3 15.161.3
2C 16.360.1 55.260.1 9.260.1 16.160.1
3A 15.560.3 53.560.3 8.060.3 19.860.3
3B 13.560.3* 62.960.8* 7.660.5 14.260.6*
BCFAs = Branched chain fatty acids; UFAs = unsaturated fatty acids;
SFAs = Saturated fatty acids.
*P,0.05 vs. respective parental strain.
doi:10.1371/journal.pone.0107426.t003
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strain-pairs. For example, for strain-pair 1, the DAP-R isolate (1C)
exhibited a significantly more relative positive surface charge than
its parental DAP-S isolate (1A). In contrast, the 3A/3B strain pair
showed the exact opposite surface charge relationships; the DAP-S
strain 3A bound more cytochrome C than did strain 3C. The 2A/
2C strain set had virtually identical surface charge readouts.
Wall teichoic acid (WTA) content (Figure 2)
A significant increase in the amount of WTA in the CW of the
DAP-S/DAP-R strain-pair 2A/2C was detected, with the DAP-R
strain producing significantly more WTA than the respective
DAP-S strain (P,0.05). In contrast, in the strain-pairs 1A/1C and
3A/3B, no difference in WTA amount in the CWs of the
respective DAP-R strains was detected.
WTA D-alanylation (Figure 3)
In addition to the significant increase in overall WTA content in
the DAP-R strain 2C, there was also a substantial difference in the
proportion of WTA that was D-alanylated when comparing strain
2C to its isogenic DAP-S strain 2A. Interestingly, the percentage of
D-alanine contained within the WTA (nmol D-alanine/nmol Pi) of
the DAP-R strains that did not exhibit an increase in WTA
content (1C and 3B) was also significantly higher than that
observed in their respective DAP-S parental strains (1A and 3A).
These latter data speak to a clear-cut gain-in-function of the DltA
gene [28,29].
CM fatty acid profiles
Fatty acid compositional data for the three strain-pairs are
shown in Table 3 (a detailed Table enumerating each specific
fatty acid species is included as Table S1). In two of the three
strain-pairs (1A–1C and 2A–2C), fatty acid composition exhibited
a rather similar overall profile, including proportionality of iso-
and ante-iso branched chain fatty acids, unsaturated fatty acids
(UFAs), and acyl chain-length profiles. Thus, the increases in CM
fluidity observed in the above two DAP-R S. aureus strains could
not be directly correlated to changes in the proportion of key fatty
acids known to impact CM fluidity; i.e, iso- vs anteiso branch
chain fatty acids, and saturated vs unsaturated fatty acids). In
contrast, in one DAP-R strain (3B), fatty acid analyses demon-
strated a significant increase in the proportion of anteiso-branch
chain species (vs iso-branch chain species) and decrease in
saturated fatty acids as compared to its respective parental DAP-
S strain (3A) (P,0.05). In this strain-pair, the total proportions of
unsaturated fatty acids were not altered, although an additional
fatty acid species (18:2v6, 9c) was present in DAP-R strain 3B.
This increase in anteiso-branch chain species appeared to
correspond with a significant reduction in the major iso-branched
chain and saturated fatty acid (SFAs) species, respectively, in this
DAP-R strain (P,0.05). These proportionality perturbations in
this latter DAP-R strain provided a potential explanation for the
observed increment in CM fluidity in this latter strain (see below).
CM phospholipid (PL) content
Since mprF regulates the lysinylation of PG to yield L-PG, as
well as its subsequent outer CM translocation, we compared these
parameters in the three DAP-S/DAP-R strain pairs. As noted in
Table 4, in strain pairs 1A/1C and 2A/2C, the DAP-R isolates
contained significantly more L-PG than their respective DAP-S
parental strains. This outcome was associated with a significant
reduction in PG content in both DAP-R isolates. For the third
strain-pair (3A/3B), an opposite readout was observed, with the
DAP-R strain containing less L-PG than its DAP-S parental strain.
Of interest, the outer CM flipping profiles for L-PG did not differ
substantially in comparing any DAP-S strain to their respective
DAP-R isolates. Thus, the net CM L-PG profile of our study
strains reflected the rate of L-PG synthesis, rather than a difference
in the extent of CM PL flipping.
CM fluidity (Figure 4)
The polarization indices (PI values) for all three DAP-R isolates
were substantially lower than that of their respective DAP-S
Table 4. Comparative cell membrane phospholipid profiles of study strains.
Strains % of total phospholipids ± SD
Inner-LPG Outer-LPG Total LPG PG CL
1A 1163.3 2.061.0 1362.8 8162.8 661.4
1C 2265.5** 562.9* 2667.3** 68610.2** 663.1
2A 962.5 261.2 1161.7 8462.3 562.1
2C 1964.0** 464.0 2466.4** 6768.9** 965.5
3A 1963.3 360.8 2263.9 6965.4 961.9
3B 1362.5** 361.3 1663.2* 8063.6** 461.7**
Abbreviations: LPG, lysyl-phosphatydylglycerol; PG, phosphatidylglycerol; CL, cardiolipin.
*P,0.05;
**P,0.01 vs respective DAP-S parental strains.
doi:10.1371/journal.pone.0107426.t004
Figure 4. Cell membrane fluidity by fluorescence polarization
indices. CM fluidity was determined by using the fluorescent prode
1,6-diphenyl-1,3,5-hexatriene (DPH). These assays were performed a
minimum of six times for each strain. Note: Lower polarization indices
= higher CM fluidity. *P,0.05 vs DAP-S parental strains.
doi:10.1371/journal.pone.0107426.g004
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parental strains, indicating that the CMs of these DAP-R isolates
were more fluid than their DAP-S counterparts. These differences
reached statistical significance for strain-pairs 2A–2C and 3A–3B.
mprF expression profiles
Figures 5A and 5B demonstrate the relative expression
profiles for mprF during exponential vs stationary growth phases
in these strain-pairs. During exponential growth, the DAP-R strain
1C showed ,4-fold increase in mprF expression vs its DAP-S
parental strain. Expression profiles for the other two strain pairs
did not demonstrate such increases among the DAP-R isolates. In
contrast, at stationary growth (when mprF expression is generally
minimal [24]), the two other DAP-R isolates (2C and 3B) exhibited
,3 and ,6-fold increases, respectively, in mprF expression as
compared to their DAP-S parental strains. Of note, this stationary
phase dysregulation of mprF expression in DAP-R strain, 3B,
occurred despite the lack of a definable SNP in mprF in this
isolate.
dltA expression profiles
As shown in Figures 6A and 6B, growth phase-dependent
dltA expression profiles for the DAP-S vs DAP-R strain-pairs
showed remarkably similar metrics as for the mprF profiles above.
Thus, dltA expression was increased in DAP-R isolates as
compared to their DAP-S parental strain at either exponential
or stationary phases of growth.
dltA and dltB sequencing
Although a few nucleotide sequence polymorphisms were
observed within the dltA and dltB among the 3 pairs of the
strains, only the DAP-R 3B strain revealed one non-synonymous
SNP (T-to-C at 763) in the dltA gene as compared to its DAP-S
Figure 5. Relative transcription level of mprF during exponential (A) and stationary (B) growth phase. RNA samples were isolated from
exponential- and stationary-phase cultures of the strains and were subjected to qRT-PCR to detect transcription of mprF and gyrA. EXPO =
exponential growth phase; ST = stationary growth phase; Fold expression = compared to gyrB gene, with parental strain fold-expression set at ‘‘1’’.
**P,0.01 vs DAP-S parental strains.
doi:10.1371/journal.pone.0107426.g005
Figure 6. Relative transcription level of dltA during exponential (A) and stationary (B) growth phase. RNA samples were isolated from
exponential- and stationary-phase cultures of the strains and were subjected to RT-PCR to detect transcription of dltA and gyrA. EXPO = exponential
growth phase; ST = stationary growth phase; Fold expression = compared to gyrB gene, with parental strain fold-expression set at ‘‘1’’. *P,0.05;
**P,0.01 vs DAP-S parental strains.
doi:10.1371/journal.pone.0107426.g006
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parental strain. This mutation yields a phenylalanine-to-leucine
(F255L) amino acid substitution (data not shown). Sequence
analyses of dltB in the three pairs revealed no differences between
the DAP-S and DAP-R pairs.
Discussion
Recently, Cafiso et al [31] have provided further evidence for
the potential role of both the CW, and specifically the dlt operon
in the DAP-R phenotype. These investigators documented the
exponential growth-phase enhancement of dlt expression in three
DAP-R MRSA strains which emerged during DAP therapy, in the
presence or absence of mprF ‘hot spot’ SNPs. These authors
proposed that dlt over-expression is a common pathway of DAP-
R. Of note, their data regarding the potential role of dlt
overexpression and DAP-R mirrors recent findings from our
own laboratories [28,29]. However, the investigation of Cafiso et
al did not elucidate potential phenotypic or genotypic mecha-
nism(s) by which dlt over-expression could be causal in DAP-R.
The current study, utilizing these same DAP-S/DAP-R strain-
pairs sought to extend and adjudicate the studies of Cafiso et al
[31]. A number of interesting observations emerged from this
investigation. First, as has been seen previously in selected DAP-R
MSSA and MRSA strains [17,28,29,51], dltA expression is
frequently dysregulated, either by enhanced exponential phase
or increased stationary phase transcription profiles. Of interest,
dltA expression is generally quite minimal at stationary phase in
DAP-S S. aureus strains [17]. Furthermore, despite these notable
differences in dltA transcription, only one of the three DAP-R
isolates exhibited a non-synonymous SNP in dltA. Phenotypically,
all three DAP-R strains demonstrated a significant increase in
their WTA D-alanylation content, reflecting DltA gains in
funtionality. Of interest, concomitant increases in CW thickness
were not observed in any of the three DAP-R strains (data not
shown).
Second, mprF expression profiles were remarkably similar to
those of dltA above in all three strain-pairs, whether or not ‘hot
spot’ non-synonymous mprF SNPs were identified in the DAP-R
isolates. The observation that mprF transcriptional dysregulation
occurred despite the absence of such SNPs supports the notion
that regulatory genes outside of mprF can affect its expression
profile. As expected, phenotypically, in the two DAP-R strains
with mprF SNPs, enhanced amounts of L-PG synthesis were
detected as compared to their respective DAP-S parental isolates.
In the remaining DAP-R strain, despite overt mprF dysregulation,
L-PG synthesis was not increased. This finding is reminiscent of
data in selected MSSA DAP-R isolates [9,24].
Third, one prevailing concept that has been put forward to
explain the DAP-R phenotype in S. aureus has been perturbations
in relative cell surface positive charge, creating a ‘‘charge
repulsion’’ scenario against calcium complexed-DAP. However,
despite the increases in dltA transcription, D-alanylation of WTA
and L-PG synthesis among the three DAP-R strains, this did not
translate into consistent enhancement of surface positive charge in
these isolates. These data refute charge repulsion as a principal or
comprehensive explanation for the DAP-R phenotype in these
strain-pairs.
Fourth, all three DAP-R strains demonstrated substantial
increases in their CM fluidity properties as compared to their
respective DAP-S parental strains. Altered CM fluidity has been
closely linked to resistance to killing by cationic antimicrobial
peptides in general [9,19,25]. Such outcomes are presumed to
relate to perturbations in the ability of such peptides to interact
with and/or insert within target CMs. It is hypothesized that there
are biophysical and/or biochemical ‘optima’ in the CM micro-
environments of S. aureus strains, making them more or less
susceptible to cognate host defense peptides (HDPs) with specific
structure-activity signatures. Thus, CMs that exhibit high degrees
of rigidity or fluidity are relatively resistant to interactions with
specific HDPs that likely rely most upon more intermediate
degrees of CM order [25,27]. The global impact of altered fluidity
in the current DAP-R vs DAP-S strains is underscored by the in
vitro ‘‘cross-resistance’’ of the DAP-R strains to cationic HDPs
which are structurally distinct from DAP, including prototypical
peptides from mammalian platelets and leukocytes. Such cross-
resistance between DAP and HDPs has been well-chronicled in
recent studies amongst both staphylococci and enterococci
[16,25,34,52,53]. The mechanism(s) of enhanced fluidity in the
current three DAP-R strains is not entirely clear, although in one
DAP-R isolate the ratio of anteiso-branch chain fatty acids
(BCFAs) was significantly increased as compared to its DAP-S
parental strain. Such iso-to-anteiso-BCFA shifts have been
previously associated with increased CM fluidity properties in
Bacillus subtilis in response to cold shock [54].
Thus, in summary, the ultimate mechanism(s) of DAP-R in S.
aureus is highly likely to be multi-factorial and strain-specific.
Although over-expression and dysregulation of dltA transcription
may well be identifiable in selected DAP-R S. aureus strains and
correlated with increased WTA D-alanylation, its subsequent
potential phenotypic consequences (i.e., changes in relative surface
charge) were not sufficient to entirely explain the DAP-R
phenotype in these strains.
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